跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,250 条关于
“ChipScreen Biosciences”
全部
2,250
临床试验
25
药物
516
机构
262
资讯
1,447
去年
Chipscreen Biosciences Receives FDA IND Approval for Brain-Penetrant Aurora B Inhibitor CS231295
去年
Chiauranib Phase III Trial Approved for Extensive-Stage Small Cell Lung Cancer
去年
Chiauranib Phase III Trial Approved for Extensive-Stage Small Cell Lung Cancer
去年
Chiauranib Approved for Phase III Trial in Extensive-Stage Small Cell Lung Cancer
5个月前
Pancreatic Cancer Pipeline Reaches New Milestone with 200+ Therapies from 170+ Companies Advancing Novel Treatment Approaches
3个月前
Soft Tissue Sarcoma Pipeline Gains Momentum: 70+ Companies Advance 75+ Therapies Across All Development Stages
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
去年
Chiglitazar Shows Promise in Phase II MASH Trial, Reduces Liver Fat and Fibrosis
2个月前
ThalassaX Doses First U.S. Patient in Phase I Trial of Brain-Penetrant Aurora B Kinase Inhibitor CS231295
去年
Over 220 Pipeline Therapies in Development for Non-Hodgkin's Lymphoma, Reports DelveInsight
第 1 页,共 145 页
上一页
下一页